TLR4 and epilepsy: The levels of HMGB1 and TLR4 increase in cerebral regions of patients with mesial temporal lobe epilepsy, focal cortical dysplasia type II (FCD-II) with epilepsy, or drug-refractory epilepsy, correlating with the severity of epilepsy (35, 100).